Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases.

Biomed J · 2021 · PMC9068516 · PMID 35300948

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Interestingly, compared to increase in 6-month LVEF (+4.87%) after SW therapy in the EnD-CAD group, the 6-month LVEF was decreased (−4.00%) in the EnD-CAD/ESRD group, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.